Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020–March 2022 - Yamayoshi, Seiya; Iwatsuki-Horimoto, Kiyoko; Okuda, Moe; Ujie, Michiko; Yasuhara, Atsuhiro; Murakami, Jurika; Duong, Calvin; Hamabata, Taiki; Ito, Mutsumi; Chiba, Shiho; Kobayashi, Ryo; Takahashi, Satoshi; et al. (Emerging infectious diseases, 2022)
Keywords: Age factors in disease; Age groups; Aged; Analysis; Antibodies; Antibodies, Viral; Antigens; Child; coronavirus disease; Coronaviruses; COVID-19; COVID-19 - epidemiology; COVID-19 - prevention & control; COVID-19 vaccines; Health facilities; Hospitals; Humans; Infections; Japan - epidemiology; Laboratories; Methods; Metropolitan areas; Pandemics; Population; Prevalence studies (Epidemiology); Proteins; respiratory infections; SARS-CoV-2; Seroepidemiologic Studies; Serology; Severe acute respiratory syndrome coronavirus 2; Vaccination; Viral infections; viruses; Japan; viruses; antibody; Japan; seroprevalence; zoonoses; respiratory infections; COVID-19; epidemiology; SARS-CoV-2; vaccine; severe acute respiratory syndrome coronavirus 2; coronavirus disease; vaccine-preventable diseases; incidence